Skip to main content

Table 3 HE4 concentrations in serum, peritoneal fluid and tumor/cyst fluid and CA125 concentrations in serum in examined subgroups of group II

From: HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases

  HE4-peritoneal fluid [pmol/L] HE4- serum [pmol/L] CA125- serum [mIU/ml] HE4 –tumor/cyst fluid [pmol/L]
Functional cysts 1799 52.6 17.3 2097
[median/95% CI] [-1152.67-4750.66] [19.53-85.67] [5.54-29.07] [-1208.38-5402.38]
Endometrial cysts 5248 45.05 56.6 15674
[median/95% CI] [-2563.74-13059.74] [31.66-58.44] [7.89-105.32] [-27785.5-59133.53]
Mature teratoma 405.3 47.65 30.15 384.3
[median/95% CI] [3.13-807.47] [30.86-64.44] [0.59-59.71] [-342.2-1110.8]
Borderline tumors 4772 84.3 39.6 30000
[median/95% CI] [-2551.87-12095.87] [30.34-138.26] [-8.83-88.03] -
Benign epithelial 2150 56.850 24.4 3872
/gonadal tumors [-5878.85-10178.85] [43.64-70.07] [-23.97-72.76] [-29543.1-37287.05]
[median/95% CI]     
Myomas 4822 58.3 90.1 -
[median/95% CI] [-2435-12079.64] [36.79-79.81] [-841.26-1021.46] -
Inflammation 498.6 65.7 113.25 -
[median/95% CI] [-573.25-1570-45] [57.09-74.31] [-136.41-362.91] -
Cirrhosis 675.95 112.6 743.75 -
[median/95% CI] [-113.78-1465.68] [28.17-196.83] [-998-2458.5] -